Le Lézard
Classified in: Health, Science and technology, Business
Subject: PER

CSI Companies Welcomes Douglas Herr as the Senior Vice President of Client Services and Strategy


CSI Companies has appointed Douglas Herr as its new Senior Vice President of Client Services and Strategy, leveraging his extensive experience in healthcare and specialization in Epic Systems and EHR solutions to drive results and impactful outcomes for clients.

JACKSONVILLE, Fla., July 2, 2024 /PRNewswire-PRWeb/ -- CSI Companies is excited to announce the appointment of Douglas Herr as Senior Vice President of Client Services and Strategy. With over 25 years of experience in healthcare, Douglas brings a specialized focus on Epic Systems and EHR solutions that will drive measurable outcomes at CSI Companies.

Drawing on his extensive background in information technology, operations, and electronic health records system implementations, Douglas has established himself as a trusted consultant in the healthcare industry. Douglas has played a pivotal role in working closely with large health systems and clinics to ensure their success across multiple large-scale implementation and optimization initiatives.

Before joining CSI, Douglas worked at Healthcare IT Leaders, where he provided clients with project support in a variety of Professional, Managed, and Activation service solutions. His years of experience in EHR and Epic-focused consulting positions with leading system integrators, including Nuance, Huron, and Leidos, further honed his expertise in addressing the diverse needs of healthcare organizations.

Douglas Herr's appointment as Senior Vice President of Client Services and Strategies represents CSI's dedication to delivering exceptional service and innovative solutions to its clients. CSI Companies is confident that Douglas' leadership will continue to elevate client services and reinforce its position as a trusted partner in the healthcare industry.

About CSI Companies:

CSI Companies is a management and consulting firm helping leading organizations solve their most pressing staffing, technology, and optimization problems. CSI combines three decades of HR and IT consulting experience, premier talent, and modernized technology to provide customized workforce solutions. CSI aims to position businesses for optimal operational efficiency, flexibility, and scalability. For more information on our healthcare IT solutions, please visit www.csicompanies.com/healthcare-it

Media Contact

Anjelica Jones, CSI Companies, 1 9044258707, [email protected], www.csicompanies.com

SOURCE CSI Companies


These press releases may also interest you

at 15:04
In the news release, Menarini's cell based non-invasive prenatal technology demonstrates high resolution detection of fetal genomic abnormalities from a simple maternal blood draw, issued 02-Jul-2024 by Menarini Silicon Biosystems over PR Newswire,...

at 14:53
The Alzheimer's Association celebrates today's U.S. Food and Drug Administration (FDA) action to approve Kisunlatm (donanemab, Eli Lilly) for the treatment of people living with early symptomatic Alzheimer's disease, which includes mild cognitive...

at 14:45
Alleva, a premier provider of electronic medical record (EMR) software solutions tailored for the behavioral health and addiction recovery sectors, is proud to announce its inclusion in the Software Advice FrontRunners for HIPAA Compliance Software...

at 14:37
Statement attributable to:Octavia Peck Palmer, PhDPresident, Association for Diagnostics & Laboratory Medicine (formerly AACC) "On June 28, in Loper Bright Enterprises v. Raimondo, the Supreme Court overturned the so-called Chevron doctrine and...

at 14:24
NanoCellect Biomedical, a leader in microfluidic cell sorting technology, proudly announces the launch of VERLOtm Image-Guided Cell Sorter, a groundbreaking cell sorter poised to redefine the landscape of single-cell visualization and gentle flow...

at 14:00
Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders, announced today...



News published on and distributed by: